Tailoring alkyl modification patterns in hyaluronic acid derivatives serving as carriers for enhanced kartogenin delivery and chondrogenic responses
Magdalena Wytrwal (AGH University of Krakow)
Sylwia Rzepa (AGH University of Krakow)
Ewa Ocłoń (University of Agriculture in Krakow)
Mirosław Kucharski (University of Agriculture in Krakow)
Ewelina Bik (AGH University of Krakow)
Katarzyna Filipek (AGH University of Krakow)
Wendy Koevoet (Erasmus MC)
Gerjo J.V.M. van Osch (TU Delft - Mechanical Engineering, Erasmus MC)
Szczepan Zapotoczny (Jagiellonian University)
More Info
expand_more
Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.
Abstract
AbstractCartilage diseases often worsen with age and require orthopedic treatment. To reduce the need for surgery, developing new methods and biomaterials to stimulate and support cartilage regeneration is essential. Among the most promising options are drug delivery systems based on hyaluronic acid (HA), a natural component of the extracellular matrix, known for its biocompatibility, biodegradability, and adjustable chemical modification. In this study, we systematically tailored alkyl modification patterns in HA by introducing alkyl chains of varying lengths and degrees of substitution. Following comprehensive physicochemical characterization, the resulting amphiphilic derivatives formed polyelectrolyte aggregates suitable for controlled delivery of bioactive molecules. Kartogenin (KGN), a small, moderately hydrophobic molecule with chondroprotective effects, was used as a model drug to test the system's potential. The engineered HA derivatives efficiently encapsulated KGN, and specific formulations promoted chondrogenesis in both 2D and 3D cultures by upregulating key chondrogenic markers. These findings highlight the importance of precise alkyl pattern design in modulating HA-based carrier behavior and pave the way for further optimization, including refined substitution strategies, ligand conjugation approaches, and expanded biocompatibility studies toward future in vivo applications.
help_outline